DE602004032457D1 - Nten - Google Patents
NtenInfo
- Publication number
- DE602004032457D1 DE602004032457D1 DE602004032457T DE602004032457T DE602004032457D1 DE 602004032457 D1 DE602004032457 D1 DE 602004032457D1 DE 602004032457 T DE602004032457 T DE 602004032457T DE 602004032457 T DE602004032457 T DE 602004032457T DE 602004032457 D1 DE602004032457 D1 DE 602004032457D1
- Authority
- DE
- Germany
- Prior art keywords
- fgf
- discovery process
- organism
- administration
- proteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
- C12N9/0073—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14) with NADH or NADPH as one donor, and incorporation of one atom of oxygen 1.14.13
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51807303P | 2003-11-07 | 2003-11-07 | |
US57224704P | 2004-05-18 | 2004-05-18 | |
PCT/EP2004/012572 WO2005045044A2 (en) | 2003-11-07 | 2004-11-05 | Use of fibroblast growth factor fragments |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004032457D1 true DE602004032457D1 (de) | 2011-06-09 |
Family
ID=34576820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004032457T Active DE602004032457D1 (de) | 2003-11-07 | 2004-11-05 | Nten |
Country Status (8)
Country | Link |
---|---|
US (3) | US20090093398A1 (de) |
EP (1) | EP1682665B1 (de) |
JP (1) | JP5118851B2 (de) |
AT (1) | ATE507296T1 (de) |
DE (1) | DE602004032457D1 (de) |
ES (1) | ES2365852T3 (de) |
HK (1) | HK1095160A1 (de) |
WO (1) | WO2005045044A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030220258A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
US7358330B2 (en) * | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
US7294704B2 (en) | 2003-08-15 | 2007-11-13 | Diadexus, Inc. | Pro108 antibody compositions and methods of use and use of Pro108 to assess cancer risk |
US20090227505A1 (en) * | 2004-01-07 | 2009-09-10 | Biotempt B.V. | Methods and uses for protein breakdown products |
JP2006347979A (ja) * | 2005-06-17 | 2006-12-28 | National Institute Of Advanced Industrial & Technology | 創傷治療及び/又は創傷治癒促進のための薬剤 |
EP1864692A1 (de) * | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Verwendung von peptiden zum Schutz von Strahlenschäden |
US11308462B2 (en) | 2014-05-13 | 2022-04-19 | Clear Token Inc | Secure electronic payment |
WO2016208776A1 (ja) | 2015-06-25 | 2016-12-29 | 株式会社国際電気通信基礎技術研究所 | 多器官連関システムを基盤とした予測装置、及び予測プログラム |
CN114778845A (zh) | 2016-03-29 | 2022-07-22 | 无限生物制药公司 | 药物组合物或食品组合物及评价活性成分体内效果的方法 |
EP4236980A1 (de) * | 2020-10-27 | 2023-09-06 | Indiana University Research and Technology Corporation | Neuartige klotho-interaktionsstelle im c-terminus von fgf23 |
CN114940990B (zh) * | 2022-06-20 | 2023-03-14 | 北京市神经外科研究所 | 与颅内动脉瘤相关的基因突变位点及其应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2075255A1 (de) * | 2000-03-08 | 2009-07-01 | Novartis Vaccines and Diagnostics, Inc. | Menschliche FGF-23-Gene und Genexpressionsprodukte |
WO2001066596A2 (en) * | 2000-03-08 | 2001-09-13 | Chiron Corporation | Human fgf-23 gene and gene expression products |
EP1303536B1 (de) * | 2000-07-19 | 2010-03-17 | Advanced Research And Technology Institute, Inc. | Neuer fibroblastwachstumsfaktor (fgf23) und methoden zur verwendung |
CA2431655A1 (en) * | 2000-11-15 | 2002-05-23 | Akiko Itai | Method of profiling protein |
JP2002223753A (ja) * | 2001-01-30 | 2002-08-13 | Hitachi Ltd | 薬物応答解析用オリゴヌクレオチドアレイ |
US20040171825A1 (en) * | 2001-04-26 | 2004-09-02 | Lydie Bougueleret | Human fibroblast growth factor-related compositions |
CA2480386A1 (en) * | 2002-03-29 | 2003-10-09 | National Institute Of Advanced Industrial Science And Technology | Novel galactose transferases, peptides thereof and nucleic acid encoding the same |
WO2003091427A1 (fr) * | 2002-04-24 | 2003-11-06 | Kansai Technology Licensing Organization Co., Ltd. | Genes associes a une nephropathie exprimes dans le tube contourne proximal |
-
2004
- 2004-11-05 EP EP04797676A patent/EP1682665B1/de not_active Not-in-force
- 2004-11-05 JP JP2006538755A patent/JP5118851B2/ja not_active Expired - Fee Related
- 2004-11-05 DE DE602004032457T patent/DE602004032457D1/de active Active
- 2004-11-05 ES ES04797676T patent/ES2365852T3/es active Active
- 2004-11-05 US US10/578,470 patent/US20090093398A1/en not_active Abandoned
- 2004-11-05 WO PCT/EP2004/012572 patent/WO2005045044A2/en active Application Filing
- 2004-11-05 AT AT04797676T patent/ATE507296T1/de not_active IP Right Cessation
-
2007
- 2007-01-05 HK HK07100210.7A patent/HK1095160A1/xx not_active IP Right Cessation
-
2011
- 2011-06-03 US US13/152,750 patent/US20120028896A1/en not_active Abandoned
-
2012
- 2012-10-19 US US13/656,084 patent/US20130040882A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2005045044A3 (en) | 2005-11-10 |
US20130040882A1 (en) | 2013-02-14 |
ATE507296T1 (de) | 2011-05-15 |
HK1095160A1 (en) | 2007-04-27 |
EP1682665A2 (de) | 2006-07-26 |
JP2007521799A (ja) | 2007-08-09 |
JP5118851B2 (ja) | 2013-01-16 |
US20090093398A1 (en) | 2009-04-09 |
EP1682665B1 (de) | 2011-04-27 |
ES2365852T3 (es) | 2011-10-11 |
WO2005045044A2 (en) | 2005-05-19 |
US20120028896A1 (en) | 2012-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1095160A1 (en) | Use of fibroblast growth factor fragments | |
Jin et al. | Conotoxins: chemistry and biology | |
Northcutt | Forebrain evolution in bony fishes | |
Lucas et al. | Mapping the lectin-like activity of tumor necrosis factor | |
CN103450348B (zh) | 一种促红细胞生成素模拟肽、其制备方法和用途 | |
Guddat et al. | Three-dimensional structure of the α-conotoxin GI at 1.2 Å resolution | |
Rich et al. | Thermodynamics of Zn2+ binding to Cys2His2 and Cys2HisCys zinc fingers and a Cys4 transcription factor site | |
Ivanov et al. | Peptidomics: a logical sequel to proteomics | |
CN108602869A (zh) | Fgf21变体 | |
Derua et al. | Analysis of the disulfide linkage pattern in circulin A and B, HIV-inhibitory macrocyclic peptides | |
Robinson et al. | Discovery by proteogenomics and characterization of an RF-amide neuropeptide from cone snail venom | |
Holford et al. | Pruning nature: Biodiversity-derived discovery of novel sodium channel blocking conotoxins from Conus bullatus | |
Chin et al. | Identification of a high-affinity receptor for interleukin 1 alpha and interleukin 1 beta on cultured human rheumatoid synovial cells. | |
ATE209684T1 (de) | Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung | |
BRPI0414793A (pt) | uso do fator anti-secretor | |
JPH07504685A (ja) | アゲレノプシス・アペルタ由来のカルシウムチャンネル阻害ポリペプチド | |
BRPI0406680A (pt) | Métodos para selecionar um animal para ter propriedades desejadas genotìpicas ou fenotìpicas em potencial, para modular a trascrição de mrna de um gene igf2 em uma célula ou organismo provido com referido gene e para identificar um composto, composto, composição farmacêutica, e, uso de um composto | |
Pan et al. | Isolation and characterization of myrmexins, six isoforms of venom proteins with anti-inflammatory activity from the tropical ant, Pseudomyrmex triplarinus | |
Pandya et al. | Integrative temporo-spatial, mineralogic, spectroscopic, and proteomic analysis of postnatal enamel development in teeth with limited growth | |
Boutin et al. | MCH-R1 antagonist GPS18169, a pseudopeptide, is a peripheral anti-obesity agent in mice | |
PL1809662T3 (pl) | Dezamidowany interferon-beta | |
Abdel-Wahab et al. | Isolation, structural identification and biological characterization of two conopeptides from the Conus pennaceus venom | |
Humpel et al. | Monitoring release of neurotrophic activity in the brains of awake rats | |
Luo et al. | Neural detection of gases—carbon dioxide, oxygen—in vertebrates and invertebrates | |
CN1034123C (zh) | 得自冬季管网蛛的钙离子通道阻断性多肽 |